Novavax Acts as Leaderboard Stock (NVAX)

Posted in pre-market 
November 30th, 2009

Novavax, Inc. (NASDAQ: NVAX) may show how little key impact news there is, but it is the top mover today in percentage terms seen.  At 8:28 AM EST we have seen 75,000 shares trade (versus 6 million average) and the stock is up 6.6% at $3.20.  This is on news that it has completed enrollment in Phase IIa studies of seasonal influenza vaccine in older adults.  The 52-week range is $0.52 to $7.79.


Comments are closed